Joint Tissue Findings Offer Potential Insight into Rheumatoid Arthritis
According to the National Institutes of Health, new research supported in part by the national Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) looking directly at joint tissue in people with arthritis is actually offering investigators an improved understanding of the antibodies involved in rheumatoid arthritis (RA), a condition in which longterm inflammation causes pain, stiffness and damage to the joints. Antibodies are molecules that participate in the immune system's protection of the body by recognizing harmful antigens such as viruses and bacteria. In RA, antibodies called autoantibodies are directed against a person's very own healthy tissues.
The NIH Explains that Two Autoantibodies
Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) - moving in the blood of many individuals with RA have been useful for diagnosing RA and also forecasting the severity, but scientists have little understanding of what these autoantibodies actually do in the joint, or whether the joints themselves might have clues to other antibodies contributing to the disease. To find some answers, NIAMS-supported researchers, Paul A. Monach, M.D., and Diane Mathis, Ph.D., and their colleagues conducted complex checks of joint tissue samples taken from 18 patients with RA.
While their study failed to necessarily find a "third antibody," the researchers did find that antibodies that came out of the joints actually bound to a lot of products associated with joint cartilage and also to histones, intracellular proteins from your cell nucleus that associate with Dna in the formation of chromosomes. The histone build up may be derived from cells that died and spilled their items, which be a consequence of the disease problem. Furthermore, they found that cartilage in RA is actually coated with histones, regardless of whether RA was active or not.
Because normal joint tissue is hardly ever removed throughout surgery, the scientists compared their findings to those from samples from eight patients with osteoarthritis (OA, a type of arthritis not generally associated with autoantibodies). The variations between the OA as well as RA samples were striking; the OA cartilage samples were not covered in histones. Right now, the scientists can not say whether histones seated on the cartilage surface are presenting to antihistone antibodies and contributing to inflammation, but that is a possibility, says Dr. Monach.
He says if histones are a contributor to joint damage, there are also other theories about their role. One is that they stimulate immune cells through a class of proteins called Toll-like receptors (TLRs). Another is that they may be key in a process that provides potentially damaging enzymes to the cartilage surface. Medical professional. Monach believes that following up on these and other hypotheses may eventually lead to the development of drugs that would intervene in or prevent the process, as well as thereby slow down shared swelling and damage in RA.
These results were published in the Proceedings of the National Academy of Sciences.
The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the U.S. Department of Health and Human Services' National Institutes of Health, is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical experts to carry out this research, and the dissemination of information on research progress in these diseases. For more information about NIAMS, phone the information Clearinghouse (877) 22-NIAMS or go to the NIAMS Web site at http://www.niams.nih.gov.
5 Major Types of Shoulder Arthritis: Osteoarthritis, Rheumatoid, Septic, Gout, Pseudogout
5 Major Types of Shoulder Joint Arthritis include Osteoarthritis, Rheumatoid Arthritis, Gout, Pseudogout and Septic Arthritis. Related Articles: Shoulder Joint ...
Flexcin & FlexPet are all-natural Joint Pain Supplements. The primary component of Flexcin & FlexPet is CM8, which relieves joint pain at its source, reduces inflammation and irritation of the joints and tissues. It has been ideal for many sufferers of arthritis, gout, bursitis, sports injuries and fibromyalgia. Flexcin and FlexPet are proudly made in the United States in a state of the art facility under the strict guidelines of the FDA's Good Manufacturing Practices.